EUVIMEDAtrasti EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC-ND 4.0

Amikacin pharmacokinetics after nebulization among intubated patients

Nicolas Gregoire, Sandrine Marchand, François Barbier, Jean-Pierre Quenot, Jean-Etienne Herbrecht, Damien Roux, Mickaël Landais, David Schnell, Anne Veinstein, Claire Dahyot-Fizelier, Nathalie Heuzé Vourc'h, Renaud Respaud and 4 more

Critical Care · 2026-04-02 · 30 (1)

DOI: 10.1186/s13054-026-05965-3 ↗

At a glance

Randomisierte kontrollierte Studie in Critical Care, published online on 2026-04-02. Written by Nicolas Gregoire and 15 co-authors. Institution: Université de Poitiers, PHAR2 INSERM U1070, PHarmacologie des Anti-infectieux et antibio-Résistance, Poitiers, France. Major MEDLINE topics: Amikacin. Cited 2 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: French ministry of health.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Santrauka nepasiekiama.

Subjects

MeSH terms (MEDLINE)

AmikacinHumansNebulizers and VaporizersMaleFemaleAnti-Bacterial AgentsMiddle AgedAgedRespiration, ArtificialIntubation, Intratracheal

Author keywords

AerosolsDrug delivery systemsMechanical ventilationVentilator associated lower respiratory tract infection

Substances

AmikacinAnti-Bacterial Agents

Authors and institutions

  • Université de Poitiers, PHAR2 INSERM U1070, PHarmacologie des Anti-infectieux et antibio-Résistance, Poitiers, France.
  • CHU de Poitiers, Service de toxicologie et pharmacologie, Poitiers, France.
  • CHR Orléans, Médecine Intensive Réanimation, Orléans, France.
  • INSERM, U1100, Research Center for Respiratory Diseases, Tours, 37032, France.
  • Department of Intensive Care, Burgundy University Hospital and Lipness Team, INSERM Research Center LNC-UMR1231 and LabEx LipSTIC, University of Burgundy, Dijon, France. INSERM CIC 1432, Clinical Epidemiology, Universit…
  • Hôpitaux Universitaires de Strasbourg, Hôpital Hautepierre, Médecine Intensive Réanimation, Strasbourg, France.

Funding

  • French ministry of health

Cite

APA

Gregoire, N., Marchand, S., Barbier, F., Quenot, J. P., Herbrecht, J. E., Roux, D., Landais, M., Schnell, D., Veinstein, A., Dahyot-Fizelier, C., Vourc'h, N. H., Respaud, R., Tavernier, E., Ehrmann, S., Reva network, & CRICS-TRIGGERSEP F-CRIN research network (2026). Amikacin pharmacokinetics after nebulization among intubated patients. Critical Care, 30(1). https://doi.org/10.1186/s13054-026-05965-3

Vancouver

Gregoire N, Marchand S, Barbier F, Quenot JP, Herbrecht JE, Roux D, et al. Amikacin pharmacokinetics after nebulization among intubated patients. Critical Care. 2026;30(1). doi:10.1186/s13054-026-05965-3

BibTeX
@article{Gregoire2026,
  author = {Gregoire, Nicolas and Marchand, Sandrine and Barbier, François and Quenot, Jean-Pierre and Herbrecht, Jean-Etienne and Roux, Damien and Landais, Mickaël and Schnell, David and Veinstein, Anne and Dahyot-Fizelier, Claire and Vourc'h, Nathalie Heuzé and Respaud, Renaud and Tavernier, Elsa and Ehrmann, Stephan and Reva network, Reva network and CRICS-TRIGGERSEP F-CRIN research network, CRICS-TRIGGERSEP F-CRIN research network},
  title = {Amikacin pharmacokinetics after nebulization among intubated patients},
  journal = {Critical Care},
  year = {2026},
  volume = {30},
  number = {1},
  doi = {10.1186/s13054-026-05965-3}
}
Start for free →